These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8369512)

  • 41. Advanced stage of chronic kidney disease is risk of poor treatment outcome for smear-positive pulmonary tuberculosis.
    Igari H; Imasawa T; Noguchi N; Nagayoshi M; Mizuno S; Ishikawa S; Kadomura M; Nishimura M; Yamagishi F
    J Infect Chemother; 2015 Aug; 21(8):559-63. PubMed ID: 26048063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
    Dutt AK; Moers D; Stead WW
    Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1232-5. PubMed ID: 2111106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Accuracy of treatment regimens performed in patients with culture positive pulmonary tuberculosis].
    Siemion-Szcześniak I; Kuś J
    Pneumonol Alergol Pol; 2005; 73(1):63-70. PubMed ID: 16539186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide in pulmonary tuberculosis patients.
    Paramasivan CN; Herbert D; Umapathy KC; Rahman F; Krishnamurthy PV; Prabhakar R
    Indian J Med Res; 1994 Jul; 100():1-4. PubMed ID: 7927544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Smear- and culture-negative pulmonary tuberculosis: four-month short-course chemotherapy.
    Dutt AK; Moers D; Stead WW
    Am Rev Respir Dis; 1989 Apr; 139(4):867-70. PubMed ID: 2930066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chemotherapy of pulmonary tuberculosis. Sputum culture conversion in 8 weeks in 84% of patients].
    Nowak D; Radenbach D; Magnussen H
    Dtsch Med Wochenschr; 1987 Sep; 112(36):1367-70. PubMed ID: 3622281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of modified short course chemotherapy in active pulmonary tuberculosis patients with human immunodeficiency virus infection in University College Hospital, Ibadan, Nigeria--a preliminary report.
    Ige OM; Sogaolu OM; Odaibo GN; Olaleye OD
    Afr J Med Med Sci; 2004 Sep; 33(3):259-62. PubMed ID: 15819474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment options and outcomes of hospitalised tuberculosis patients: a nationwide study.
    Yamana H; Matsui H; Fushimi K; Yasunaga H
    Int J Tuberc Lung Dis; 2015 Jan; 19(1):120-6. PubMed ID: 25519801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa.
    Kassim S; Sassan-Morokro M; Ackah A; Abouya LY; Digbeu H; Yesso G; Coulibaly IM; Coulibaly D; Whitaker PJ; Doorly R
    AIDS; 1995 Oct; 9(10):1185-91. PubMed ID: 8519456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the District Tuberculosis Programme.
    Suryanarayana HV; Chakraborty AK
    Tuber Lung Dis; 1994 Oct; 75(5):395-7. PubMed ID: 7841436
    [No Abstract]   [Full Text] [Related]  

  • 51. Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Tanzania/British Medical Research Council Study.
    Am Rev Respir Dis; 1985 May; 131(5):727-31. PubMed ID: 3890640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. China Tuberculosis Control Collaboration.
    Lancet; 1996 Feb; 347(8998):358-62. PubMed ID: 8598701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relapse after short-course chemotherapy of patients with sputum smear-positive pulmonary tuberculosis under routine conditions with additional information on side effects and contact tracing.
    Martinez FD; Hernandez HM
    Tuber Lung Dis; 1996 Oct; 77(5):425-8. PubMed ID: 8959146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effectiveness and tolerance of antituberculosis treatment regimens without isoniazid and rifampicin: analysis of 85 cases].
    Tost JR; Vidal R; Maldonado J; Caylà JA
    Arch Bronconeumol; 2008 Sep; 44(9):478-83. PubMed ID: 19000510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Reasons for chronic expectoration in patients with pulmonary tuberculosis registered in the Central Tuberculosis Registry].
    Korzeniewska-Koseła M; Michałowska-Mitczuk D; Wedzicha S; Pawlicka L; Miller M; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):181-6. PubMed ID: 9489413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reasons for chronic sputum culture positive tuberculosis--evaluation based on personal experience].
    Michałowska-Mitczuk D; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):157-63. PubMed ID: 9489410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum drug concentrations of INH and RMP predict 2-month sputum culture results in tuberculosis patients.
    Mah A; Kharrat H; Ahmed R; Gao Z; Der E; Hansen E; Long R; Kunimoto D; Cooper R
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):210-5. PubMed ID: 25574921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of pulmonary tuberculosis with short course chemotherapy in south India--5-year follow up.
    Santha T; Nazareth O; Krishnamurthy MS; Balasubramanian R; Vijayan VK; Janardhanam B; Venkataraman P; Tripathy SP; Prabhakar R
    Tubercle; 1989 Dec; 70(4):229-34. PubMed ID: 2516669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Follow-up of tuberculosis patients undergoing standard anti-tuberculosis chemotherapy by using a polymerase chain reaction.
    Levée G; Glaziou P; Gicquel B; Chanteau S
    Res Microbiol; 1994 Jan; 145(1):5-8. PubMed ID: 8090986
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia.
    Mawer C; Ignatenko N; Wares D; Strelis A; Golubchikova V; Yanova G; Lyagoshina T; Sharaburova O; Banatvala N
    Lancet; 2001 Aug; 358(9280):445-9. PubMed ID: 11513907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.